Learn more about the Neuromod Prize by attending a virtual information session on February 7. The National Institutes of Health (NIH) team will give an in-depth overview of the competition and answer questions.
A video recording of the session, as well as a summary of questions and answers, will be shared following the event.
More about the $9.8 million competition
The Neuromod Prize is a SPARC (Stimulating Peripheral Activity to Relieve Conditions) initiative from NIH that is accelerating the development of targeted neuromodulation therapies. The first phase calls on scientists, engineers, and clinicians to submit novel concepts and plans for development.
The competition is open to U.S. participants, subject to eligibility requirements. Phase 1 participants will submit concept papers describing their proposed therapeutic approaches, their plans for conducting proof-of-concept studies, their rationales for therapeutic use, and their expectations for clinical impact. Submissions are due by 4:59 p.m. EDT on April 28.
Explore the Neuromod Prize resource hub to learn more about present and emerging methods for bioelectronic medicine, research tools, clinical translation, and target performance considerations.
Sign up to receive all competition updates: Subscribe to the Neuromod Prize newsletter.